Terms: = Brain cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Treatment
65 results:
1. Germline Mutations of Holliday Junction Resolvase Genes in Multiple Primary Malignancies Involving Lung cancer Lead to PARP Inhibitor Sensitization.
Wang H; Chen Y; Wang X; Huang B; Xie J; Yin H; Yang J; Wu J; Yuan J; Zhang J
Clin Cancer Res; 2024 Apr; 30(8):1607-1618. PubMed ID: 38349998
[TBL] [Abstract] [Full Text] [Related]
2. Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.
Wang H; Yee D; Potter D; Jewett P; Yau C; Beckwith H; Watson A; O'Grady N; Wilson A; Brain S; Pohlmann P; ; Blaes A
Breast Cancer Res Treat; 2024 Apr; 204(3):589-597. PubMed ID: 38216819
[TBL] [Abstract] [Full Text] [Related]
3. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Zeng Q; Klein C; Caruso S; Maille P; Allende DS; Mínguez B; Iavarone M; Ningarhari M; Casadei-Gardini A; Pedica F; Rimini M; Perbellini R; Boulagnon-Rombi C; Heurgué A; Maggioni M; Rela M; Vij M; Baulande S; Legoix P; Lameiras S; ; Bruges L; Gnemmi V; Nault JC; Campani C; Rhee H; Park YN; Iñarrairaegui M; Garcia-Porrero G; Argemi J; Sangro B; D'Alessio A; Scheiner B; Pinato DJ; Pinter M; Paradis V; Beaufrère A; Peter S; Rimassa L; Di Tommaso L; Vogel A; Michalak S; Boursier J; Loménie N; Ziol M; Calderaro J
Lancet Oncol; 2023 Dec; 24(12):1411-1422. PubMed ID: 37951222
[TBL] [Abstract] [Full Text] [Related]
4. Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis.
Ballo MT; Conlon P; Lavy-Shahaf G; Kinzel A; Vymazal J; Rulseh AM
J Neurooncol; 2023 Aug; 164(1):1-9. PubMed ID: 37493865
[TBL] [Abstract] [Full Text] [Related]
5. Nomograms for predicting overall survival in colorectal cancer patients with metastasis to the liver, lung, bone, and brain.
Wang H; Shan X; Zhang M; Qian K; Shen Z; Zhou W
Cancer Causes Control; 2023 Dec; 34(12):1059-1072. PubMed ID: 37486401
[TBL] [Abstract] [Full Text] [Related]
6. Endoscopic versus Nonendoscopic Surgery for Resection of Craniopharyngiomas.
Abiri A; Roman KM; Latif K; Goshtasbi K; Torabi SJ; Lehrich BM; Mohyeldin A; Hsu FPK; Kuan EC
World Neurosurg; 2022 Nov; 167():e629-e638. PubMed ID: 36041722
[TBL] [Abstract] [Full Text] [Related]
7. ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide.
Raghava Kurup R; Oakes EK; Vadlamani P; Nwosu O; Danthi P; Hundley HA
Sci Rep; 2022 Aug; 12(1):13362. PubMed ID: 35922651
[TBL] [Abstract] [Full Text] [Related]
8. Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases.
Xie XY; Peng HH; Zhang X; Pan YL; Zhang Z; Cao PG
Radiat Oncol; 2022 Jul; 17(1):132. PubMed ID: 35883147
[TBL] [Abstract] [Full Text] [Related]
9. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.
Schnöller LE; Albrecht V; Brix N; Nieto AE; Fleischmann DF; Niyazi M; Hess J; Belka C; Unger K; Lauber K; Orth M
Radiat Oncol; 2022 Apr; 17(1):79. PubMed ID: 35440003
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials.
Zhao P; Zhen H; Zhao H; Zhao L; Cao B
BMC Cancer; 2022 Mar; 22(1):328. PubMed ID: 35346117
[TBL] [Abstract] [Full Text] [Related]
11. ASCEND-7: Efficacy and Safety of Ceritinib treatment in Patients with ALK-Positive Non-Small Cell Lung cancer Metastatic to the brain and/or Leptomeninges.
Chow LQM; Barlesi F; Bertino EM; van den Bent MJ; Wakelee HA; Wen PY; Chiu CH; Orlov S; Chiari R; Majem M; McKeage M; Yu CJ; Garrido P; Hurtado FK; Arratia PC; Song Y; Branle F; Shi M; Kim DW
Clin Cancer Res; 2022 Jun; 28(12):2506-2516. PubMed ID: 35091443
[TBL] [Abstract] [Full Text] [Related]
12. Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Tawbi HA; Forsyth PA; Hodi FS; Algazi AP; Hamid O; Lao CD; Moschos SJ; Atkins MB; Lewis K; Postow MA; Thomas RP; Glaspy J; Jang S; Khushalani NI; Pavlick AC; Ernstoff MS; Reardon DA; Kudchadkar R; Tarhini A; Chung C; Ritchings C; Durani P; Askelson M; Puzanov I; Margolin KA
Lancet Oncol; 2021 Dec; 22(12):1692-1704. PubMed ID: 34774225
[TBL] [Abstract] [Full Text] [Related]
13. Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors.
Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Bailo M; Piloni M; Spina A; Fodor A; Berzero G; Di Muzio N; Filippi M; Finocchiaro G; Mortini P
Crit Rev Oncol Hematol; 2021 Dec; 168():103508. PubMed ID: 34678323
[TBL] [Abstract] [Full Text] [Related]
14. Postsurgical geometrical variations of tumor bed and brainstem during photon and proton therapy for pediatric tumors of the posterior fossa: dosimetric impact and predictive factors.
Volpe S; Bondiau PY; Claude L; Claren A; Padovani L; AlGhamdi H; Duhil De Benaze G; Opitz L; Baudin G; Dejean C; Maneval D; Jereczek-Fossa BA; Doyen J
Strahlenther Onkol; 2021 Dec; 197(12):1113-1123. PubMed ID: 34351450
[TBL] [Abstract] [Full Text] [Related]
15. Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study.
Tosoni A; Gatto L; Franceschi E; Di Nunno V; Lodi R; Mura A; Di Battista M; Bartolini S; Brandes AA
Eur J Cancer; 2021 Mar; 145():171-178. PubMed ID: 33486440
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of Surgical Resection and Stereotactic Radiosurgery in the Initial treatment of brain Metastasis.
Liu Z; He S; Li L
Stereotact Funct Neurosurg; 2020; 98(6):404-415. PubMed ID: 32898850
[TBL] [Abstract] [Full Text] [Related]
17. Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia.
Kim B; Yun W; Lee ST; Choi JR; Yoo KH; Koo HH; Jung CW; Kim SH
Sci Rep; 2020 Aug; 10(1):14297. PubMed ID: 32868804
[TBL] [Abstract] [Full Text] [Related]
18. Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas.
Franceschi E; Tosoni A; Bartolini S; Minichillo S; Mura A; Asioli S; Bartolini D; Gardiman M; Gessi M; Ghimenton C; Giangaspero F; Lanza G; Marucci G; Novello M; Silini EM; Zunarelli E; Paccapelo A; Brandes AA
Eur J Cancer; 2020 Sep; 137():10-17. PubMed ID: 32721633
[TBL] [Abstract] [Full Text] [Related]
19. Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1.
Gallitto M; Cheng He R; Inocencio JF; Wang H; Zhang Y; Deikus G; Wasserman I; Strahl M; Smith M; Sebra R; Yong RL
J Neurooncol; 2020 May; 147(3):557-566. PubMed ID: 32193690
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of Survival of Patients with brain Metastases According to Prognostic Indexes and treatment Strategies.
Saginc H; Baltalarli PB; Sagtas E; Coskun ME
Turk Neurosurg; 2020; 30(6):822-831. PubMed ID: 32091122
[TBL] [Abstract] [Full Text] [Related]
[Next]
